Peroxiredoxin 6 mediates acetaminophen-induced hepatocyte death through JNK activation

[1]  H. Jaeschke,et al.  Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential , 2016, Redox biology.

[2]  N. Kaplowitz,et al.  c‐Jun N‐terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)‐dependent pathway leading to inactivation of intramitochondrial Src , 2016, Hepatology.

[3]  D. Yoon,et al.  Exacerbation of Collagen Antibody–Induced Arthritis in Transgenic Mice Overexpressing Peroxiredoxin 6 , 2015, Arthritis & rheumatology.

[4]  Mitchell R. McGill,et al.  Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase. , 2014, Toxicology and applied pharmacology.

[5]  F. Larsen,et al.  Understanding paracetamol-induced liver failure , 2014, Intensive Care Medicine.

[6]  T. Kavanagh,et al.  Acetaminophen-induced liver damage in mice is associated with gender-specific adduction of peroxiredoxin-6 , 2014, Redox biology.

[7]  Y. Sasaguri,et al.  Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. , 2013, Antioxidants & redox signaling.

[8]  Neil Kaplowitz,et al.  Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. , 2013, Trends in pharmacological sciences.

[9]  K. Huh,et al.  Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression , 2012 .

[10]  N. Kaplowitz,et al.  c-Jun N-terminal Kinase (JNK)-dependent Acute Liver Injury from Acetaminophen or Tumor Necrosis Factor (TNF) Requires Mitochondrial Sab Protein Expression in Mice* , 2011, The Journal of Biological Chemistry.

[11]  A. Fisher,et al.  Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities. , 2011, Antioxidants & redox signaling.

[12]  P. Lograsso,et al.  Mitochondrial c-Jun N-terminal Kinase (JNK) Signaling Initiates Physiological Changes Resulting in Amplification of Reactive Oxygen Species Generation* , 2011, The Journal of Biological Chemistry.

[13]  James R. Roede,et al.  Overexpression of Peroxiredoxin 6 Does Not Prevent Ethanol-Mediated Oxidative Stress and May Play a Role in Hepatic Lipid Accumulation , 2009, Journal of Pharmacology and Experimental Therapeutics.

[14]  C. Dodia,et al.  Binding of peroxiredoxin 6 to substrate determines differential phospholipid hydroperoxide peroxidase and phospholipase A(2) activities. , 2009, Archives of biochemistry and biophysics.

[15]  Jae-Hyuck Shim,et al.  H2O2-dependent Hyperoxidation of Peroxiredoxin 6 (Prdx6) Plays a Role in Cellular Toxicity via Up-regulation of iPLA2 Activity* , 2008, Journal of Biological Chemistry.

[16]  Neil Kaplowitz,et al.  Role of JNK Translocation to Mitochondria Leading to Inhibition of Mitochondria Bioenergetics in Acetaminophen-induced Liver Injury* , 2008, Journal of Biological Chemistry.

[17]  Cuk-Seong Kim,et al.  Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock , 2007, The Journal of experimental medicine.

[18]  N. Kaplowitz,et al.  c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. , 2006, Gastroenterology.

[19]  N. Kaplowitz,et al.  Neutrophil depletion protects against murine acetaminophen hepatotoxicity , 2006, Hepatology.

[20]  Neil Kaplowitz,et al.  Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. , 2003, Molecular pharmacology.

[21]  Satoshi Tsukada,et al.  A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. , 2002, The Biochemical journal.

[22]  S. Rhee,et al.  Peroxiredoxin, a Novel Family of Peroxidases , 2001, IUBMB life.

[23]  C. Dodia,et al.  1-Cys Peroxiredoxin, a Bifunctional Enzyme with Glutathione Peroxidase and Phospholipase A2 Activities* , 2000, The Journal of Biological Chemistry.

[24]  Steven D. Cohen,et al.  Selective protein covalent binding and target organ toxicity. , 1997, Toxicology and applied pharmacology.

[25]  P. Burcham,et al.  Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. , 1991, The Journal of biological chemistry.

[26]  H. Jaeschke,et al.  Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. , 1990, The Journal of pharmacology and experimental therapeutics.

[27]  Steven D. Cohen,et al.  Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. , 1988, Toxicology and applied pharmacology.

[28]  A. Y. Lu,et al.  N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Wieckowski,et al.  Isolation of crude mitochondrial fraction from cells. , 2015, Methods in molecular biology.

[30]  G. Gores,et al.  Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[31]  K. Huh,et al.  Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression. , 2012, Antioxidants & redox signaling.

[32]  S. Dooley,et al.  Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism , 2011, Archives of Toxicology.

[33]  T. Davern,et al.  Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study , 2005, Hepatology.

[34]  William M. Lee,et al.  LIVER FAILURE AND LIVER DISEASE LIVER FAILURE Acetaminophen-Induced Acute Liver Failure: Results of a United States Multicenter, Prospective Study , 2005 .